United States· US:55150-337_107c9155-9130-4202-b2e4-4c7732561420
BORTEZOMIB
A medicinal product containing bortezomib, registered in United States by Eugia US LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BORTEZOMIB
- Manufacturer
- Eugia US LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1155150337011 VIAL, SINGLE-DOSE in 1 CARTON (55150-337-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
- ndc1155150-337-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bortezomib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainBORTEZOMIB ACCORD 1 MG POLVO PARA SOLUCION INYECTABLE EFGAccord Healthcare S.L.U.
- GermanyBortezomibNovumgen Limited
- NetherlandsBortezomib Accord 1 mg, poeder voor oplossing voor injectieAccord Healthcare S.L.U.
- FinlandBortezomib AccordAccord Healthcare S.L.U.
- United KingdomBortezomib 1.6mg/0.64ml in Sodium chloride 0.9% solution for injection pre-filled syringesSpecial Order
- PolandBortezomib AccordAccord Healthcare S.L.U.
- SwedenBortezomib Accord 1 mg Pulver till injektionsvätska, lösningAccord Healthcare S.L.U.
- CzechiaBORTEZOMIB ACCORDAccord Healthcare S.L.U., Barcelona
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Abormib, Bortezomib Ever Pharma
- Belgium · Bortezomib Eg, Bortezomib Eugia
- Bulgaria · Bortezomib Ever Pharma, Бортезомиб Актавис
- Cyprus · Bortezomib Pharmazac, Bortezomib Stada
- Czechia · Bortezomib Ever Pharma, Bortezomib Msn
- Germany · Bortezomib, Bortezomib Amarox
- Denmark · Bortezomib Actavis, Bortezomib Ever Pharma
- Spain · Bortezomib Aurovitas, Bortezomib Combix
- Finland · Bortezomib Avansor, Bortezomib Ever Pharma
- France · Bortezomib, Bortezomib Arrow
- United Kingdom (Northern Ireland) · Bortezomib, Bortezomib Accord
- Greece · Bortezomib Pharmazac, Bortezomib Sandoz
- Croatia · Bortezomib Alpha-Medical, Bortezomib Ever Pharma
- Hungary · Bortezomib Ever Pharma, Bortezomib Msn
- Ireland · Bortezomib Aspire Pharma (Malta), Bortezomib Biotech Pharma Limited
- Iceland · Bortezomib Accord, Bortezomib Actavis
- Italy · Bortezomib Aurobindo, Bortezomib Dr. Reddy’s
- Liechtenstein · Bortezomib Accord, Bortezomib Fresenius Kabi
- Luxembourg · Bortezomib Eg
- Latvia · Bortezomib Tzf
- Malta · Bortezomib Clonmel, Bortezomib Dr. Reddy’s
- Netherlands · Bortezomib Amarox, Bortezomib Cf
- Norway · Bortezomib Accord, Bortezomib Ever Pharma
- Poland · Adabonib, Bortezomib Eugia
- Portugal · Bortezomib Ever Pharma, Bortezomib Extrovis
- Romania · Bortezomib, Bortezomib Dr. Reddy’s
- Sweden · Bortezomib Avansor, Bortezomib Ever Pharma
- Slovenia · Bortezomib Actavis, Bortezomib Ever Pharma
- Slovakia · Bortezomib Ever Pharma, Bortezomib Glenmark
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f57da063-ec92-4c43-98f0-e1db6c7b3ecf GET /v1/drugs/f57da063-ec92-4c43-98f0-e1db6c7b3ecf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS; SUBCUTANEOUS",
"source": "ndc",
"strength": "3.5",
"substance": "BORTEZOMIB",
"productndc": "55150-337",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA212825",
"marketing_category": "ANDA"
}See everything about bortezomib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.